At a meeting of SNBTS and heamophilia directors Dr Forbes spoke of findings relating to HTLV 3 antibody seroconversion in a comparative study of haemophilia patients in Glasgow and Denmark.
Chronology Information
Date:
Chapter/issue
Haemophilia Centres: Policies and Practice
Key Person(s)
Dr Charles Douglas Forbes